Austrian Left Atrial Appendage Closure Registry

Recruiting

• Conditions: Atrial Fibrillation; Left Atrial Appendage Closure

• Registration Number: NCT03409159
• Lead Sponsor: Medical University of Graz

Brief Summary

Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-05-16
• Study First Submitted: 2017-11-24
• Study First Submitted QC: 2018-01-17
• Study First Posted: 2018-01-24
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-19
• Last Update Posted: 2024-11-21
• Primary Completion: 2025-12
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients who received LAAC in Austria

Exclusion Criteria

• Absence of informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of participants with successful left atrial appendage closure, as defined by European Society of Cardiology Guidelines	30 days

Secondary Outcome Measures

Name	Time	Method
Number of participants with death, stroke or bleeding	5 years
Number of participants with procedure-related adverse events	30 days

Trial Locations

Locations (1)

Medical University of Graz; 🇦🇹 Graz, Austria